Newfound cancer cell biology suggests which patients will respond to immunotherapy
Patients with head and neck cancer who have more genetic material on chromosome 9 in their cancer cells survive three times longer after receiving immunotherapy than those with less genetic material there.
Materials provided by NYU Langone Health / NYU Grossman School of Medicine. Note: Content may be edited for style and length.
Source link aaaaa